Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease

NCT07580092 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07580092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
November 30, 2023
Completion date
March 5, 2026
Enrollment
6,967 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, inflammatory joint disease (ijd), polyarthritis, psoriatic arthritis, rheumatoid arthritis (ra)